Concepedia

Publication | Open Access

A real-world study on SGLT2 inhibitors and diabetic kidney disease progression

DOIFull Paper Access

31

Citations

30

References

2022

Year

Allen Yan Lun Liu, Serena Low, Ester Yeoh, Eng Kuang Lim, Claude J. Renaud, Selene T. Y. Teoh, Grace Feng Ling Tan, Chung Cheen Chai, Bo Liu, Tavintharan Subramaniam,
Clinical Kidney Journal

Abstract

This real-world study demonstrates the benefits of SGLT2is on CKD progression and ESKD. The effect is more pronounced in moderate to advanced CKD patients.

References

YearCitations

Page 1